Navigation Links
Unisense FertiliTech A/S Secures 24 Million USD in New Capital Investment
Date:12/13/2012

AARHUS, Denmark, December 13, 2012 /PRNewswire/ --

Danish medtech company Unisense FertiliTech A/S announces a new partnership with Oticon Funds investment company William Demant Invest (WDI). WDI owns 32% of Unisense FertiliTech A/S after the purchase of new and existing shares in the company worth 24 million USD.

     (Photo: http://photos.prnewswire.com/prnh/20120918/562489 )

Unisense FertiliTech A/S develops and manufactures products to improve treatment in the field of assisted reproduction.  The company has expanded rapidly in the past 2 years, operating in more than 30 countries worldwide.  In addition to the current hardware and software product offerings, there is an exciting pipeline of products under development which hold significant commercial potential within the IVF industry.

With this new partnership and investment, the company will be in an excellent position to execute its long term development strategy and to accelerate the global expansion of sales of FertiliTech's existing and new products geared towards improving clinical practice in the field of IVF.

"We welcome WDI as an extremely knowledgeable, financially strong and experienced investor with a proven track record in the medtech field. We also look much forward to the benefits and synergies that can be achieved when applying extensive experience from the hearing aid industry to the area of assisted reproduction", says Unisense FertiliTech A/S CEO, Jens Gundersen.

William Demant Invest's CEO, Niels Jacobsen is very satisfied with the new investment and future goals: "We see excellent possibilities with FertiliTech.  It is a very professionally driven organization with a huge potential. In addition, their products and company profile are a good fit with our existing portfolio".

About Unisense FertiliTech A/S (UF)

Unisense FertiliTech A/S was founded in 2003 to develop technology to improve human embryo assessment in assisted reproduction. Initial research using bovine models led the way to collaborations with embryologists in Europe and North America to evaluate our technology for use with human embryos. Towards this end, an instrument incorporating a fully stable incubation environment with integrated time-lapse image acquisition was developed.

Unisense FertiliTech A/S manufactures and sells state-of-the-art instrumentation notably the EmbryoScope® Time-lapse system, the EmbryoViewer® Workstation (Software) and related products, which are EU approved and FDA cleared for clinical use in IVF laboratories. Unisense FertiliTech A/S conforms to the requirements in DS/EN ISO 13485:2012 for production, installation and servicing of IVF incubators and related accessories

The company is involved in numerous international collaborations, and strives to develop embryo assessment algorithms to improve embryo selection and workflow in the assisted reproduction laboratory. Our goal is to promote knowledge building through extensive documentation and retrospective analysis. We are dedicated to providing technology to improve IVF treatment through quantification of embryo development patterns.

About William Demant Invest

WDI is a wholly owned subsidiary of the Oticon Foundation and has consolidated financial statements with the Oticon Foundation. The objective of the Oticon Foundation's investment activities is to achieve a long-term stable return that will secure the Oticon Foundation's capital its obligations under section 3 of the foundation charter. To achieve this, the financial long-term goals are to maintain or increase the real value of investment assets and to provide a relatively stable return to be used for donations and grants.

The Oticon Foundation's statutes mandate that income be used to support the needs of hearing-impaired individuals as well as organizations. Income is derived through its operational activities in William Demant Invest.

Having a long history, the Oticon Foundation sponsors social and educational programs, publications, conferences, cultural activities and campaigns - both for researchers, hearing-care professionals and the general public.

website  http://www.fertilitech.com



'/>"/>
SOURCE Unisense FertiliTech A/S
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Unisense FertiliTech A/S sichert 24 Millionen USD an neuen Kapitalinvestitionen
2. Biomatrica Secures Financing of $5 Million
3. SurgiQuest, Inc. Secures Additional $18.5 Million Funding to Fuel Worldwide Expansion and Commercialization Efforts
4. Zafgen Secures $21 Million in Series D Financing
5. Flexion Therapeutics Secures $20 Million in Series B Financing
6. Principia Biopharma Secures $12.5M Second Tranche In Series A Financing, Expands Senior Management Team
7. ROX Medical secures financing and achieves key milestones in providing minimally-invasive approach for treating hypertension
8. BioMotiv Secures $21 million in Initial Funding
9. Alexza Secures a $20 Million Committed Equity Financing Facility with Azimuth Opportunity, L.P.
10. Dr. Jills Foot Pads Secures GSA Schedule and Expands to Service VA and Federal Agencies
11. PLC Systems Secures Additional Financing For US Clinical Trials And General Working Capital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 ... Tomorrow,s Leaders Scholarship is any indication, the future is ... online at www.diabetesscholars.org by the Diabetes Scholars ... in the way of academic and community service excellence. ... program since 2012, and continues to advocate for people ...
(Date:6/23/2016)... Revolutionary technology includes multi-speaker listening ... industry leaders in advanced audiology and hearing aid technology, ... ™, the world,s first internet connected hearing aid that ...      (Photo: http://photos.prnewswire.com/prnh/20160622/382240 ) , ... ,world firsts,: , TwinLink™ - the first ...
(Date:6/23/2016)... 2016 The vast majority of dialysis patients ... Treatments are usually 3 times a week, with treatment ... travel time, equipment preparation and wait time.  This regimen ... for patients who are elderly and frail.  Many elderly ... rehabilitation centers for some duration of time. ...
Breaking Medicine Technology:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... cutting edge technology to revolutionize the emergency ambulance transport experience for the millions ... aware of how Uber has disrupted the taxi industry through the use of ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Pixel Film ... Pro X. , "Film editors can give their videos a whole new perspective by ... Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from ... at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center ... care topics including advance care planning, healthcare costs and patient and family engagement. ...
(Date:6/25/2016)... Lewisville, TX (PRWEB) , ... June 25, 2016 , ... ... in the United States, named Dr. Sesan Ogunleye, as the Medical Director of its ... be the facility Medical Director of our new Mesquite location,” said Dr. James M. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
Breaking Medicine News(10 mins):